Steven Powell is the founder of eTheRNA immunotherapies. eTheRNA immunotherapies has raised $63M in total funding. Latest round: Series B.
Steven Powell is a biotechnology executive who previously served as CEO of the Belgian clinical-stage company eTheRNA Immunotherapies, guiding it through multiple funding rounds. He has since transitioned to CEO of Ribonexus and holds a Non-Executive Director role at eTheRNA.
Full founder directory · Investor directory · Company funding database · Fundraising library